Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 juil. 2024 07h00 HE | Source: Draupnir Bio

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...
23 sept. 2021 07h00 HE | Source: Draupnir Bio

Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease

Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...
23 sept. 2021 02h00 HE | Source: Draupnir Bio

Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease

Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...